Strs Ohio Grows Stock Position in Teleflex Incorporated $TFX

Strs Ohio grew its position in Teleflex Incorporated (NYSE:TFX) by 4.9% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 23,067 shares of the medical technology company’s stock after purchasing an additional 1,067 shares during the period. Strs Ohio owned approximately 0.05% of Teleflex worth $2,730,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of the company. T. Rowe Price Investment Management Inc. increased its holdings in shares of Teleflex by 0.7% in the first quarter. T. Rowe Price Investment Management Inc. now owns 6,216,763 shares of the medical technology company’s stock valued at $859,095,000 after purchasing an additional 43,642 shares during the period. Dimensional Fund Advisors LP increased its holdings in shares of Teleflex by 69.5% in the first quarter. Dimensional Fund Advisors LP now owns 867,864 shares of the medical technology company’s stock valued at $119,927,000 after purchasing an additional 355,720 shares during the period. Diamond Hill Capital Management Inc. increased its holdings in shares of Teleflex by 122.8% in the first quarter. Diamond Hill Capital Management Inc. now owns 584,586 shares of the medical technology company’s stock valued at $80,784,000 after purchasing an additional 322,222 shares during the period. TD Asset Management Inc increased its holdings in shares of Teleflex by 0.7% in the first quarter. TD Asset Management Inc now owns 490,000 shares of the medical technology company’s stock valued at $67,713,000 after purchasing an additional 3,310 shares during the period. Finally, Millennium Management LLC increased its holdings in shares of Teleflex by 57.8% in the first quarter. Millennium Management LLC now owns 394,633 shares of the medical technology company’s stock valued at $54,534,000 after purchasing an additional 144,531 shares during the period. 95.62% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages have recently weighed in on TFX. Zacks Research lowered Teleflex from a “strong-buy” rating to a “hold” rating in a report on Tuesday, September 30th. Wells Fargo & Company cut their price objective on Teleflex from $137.00 to $131.00 and set an “equal weight” rating on the stock in a report on Friday, August 1st. Mizuho raised their target price on Teleflex from $130.00 to $135.00 and gave the stock a “neutral” rating in a report on Friday, August 1st. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Teleflex in a report on Wednesday, October 8th. Finally, Wall Street Zen lowered Teleflex from a “strong-buy” rating to a “buy” rating in a report on Monday, September 15th. One analyst has rated the stock with a Buy rating, nine have assigned a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Reduce” and a consensus target price of $141.57.

Insider Buying and Selling

In other Teleflex news, Director Gretchen R. Haggerty purchased 500 shares of the firm’s stock in a transaction dated Wednesday, August 6th. The shares were acquired at an average price of $114.75 per share, with a total value of $57,375.00. Following the purchase, the director directly owned 6,305 shares in the company, valued at approximately $723,498.75. This trade represents a 8.61% increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website. 1.40% of the stock is owned by corporate insiders.

Teleflex Stock Down 1.5%

Shares of TFX opened at $122.66 on Tuesday. The company has a current ratio of 2.41, a quick ratio of 1.44 and a debt-to-equity ratio of 0.42. Teleflex Incorporated has a 12 month low of $108.90 and a 12 month high of $212.16. The stock’s 50 day moving average is $126.51 and its two-hundred day moving average is $123.39. The firm has a market cap of $5.42 billion, a P/E ratio of 28.86, a PEG ratio of 1.79 and a beta of 1.05.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.